# Premier Biomedical, Inc. (BIEI)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BIEI/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 58.3K | $ 5.6K | N/A | $ 740.6K | $ -2.57M |
| 2025 | $ 0 | $ -89.5K | $ -20.0K | $ 750.6K | $ -2.61M |
| 2024 | $ 0 | $ -103.9K | N/A | $ 607.6K | $ -2.58M |
| 2023 | $ 0 | $ -218.1K | $ -184.9K | $ 568.3K | $ -2.48M |
| 2022 | $ 0 | $ -55.0K | $ -632 | $ 437.4K | $ -2.28M |
| 2021 | $ 0 | $ -46.1K | $ -5.9K | $ 436.0K | $ -2.25M |
| 2020 | $ 1.3K | $ -513.2K | N/A | N/A | N/A |
| 2019 | $ 18.4K | $ -483.3K | $ -450.5K | $ 160.7K | $ -1.83M |
| 2018 | $ 52.6K | $ -527.2K | $ -590.2K | $ 309.6K | $ -2.15M |
| 2017 | $ 53.6K | $ -5.07M | $ -689.9K | $ 170.0K | $ -2.61M |
| 2016 | $ 0 | $ -2.43M | $ -670.2K | $ 183.0K | $ -660.7K |
| 2015 | $ 0 | $ -3.62M | $ -649.0K | $ 94.6K | $ -276.3K |
| 2014 | $ 0 | $ -1.99M | $ -906.4K | $ 14.9K | $ -67.8K |
| 2013 | $ 0 | $ -6.94M | $ -611.0K | $ 109.0K | $ -249.0K |
| 2012 | $ 0 | $ -2.47M | $ -193.7K | $ 12.0K | $ -75.8K |
| 2011 | $ 0 | $ -164.3K | $ -144.7K | $ 0 | $ 30.2K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.29 |
| Liabilities / Eq | -1.02 |
| Current Ratio | 0.02 |

## Other views

- [Metrics](https://sponda.capital/en/BIEI.md)
- [Charts](https://sponda.capital/en/BIEI/charts.md)
- [Compare](https://sponda.capital/en/BIEI/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.
